J Cassidy

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

P. Vasey, Stan B. Kaye, Rachel Morrison et al. · PubMed · 1999 · 691 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation.

Earl J. Brewer, Juan Bass, John Baum et al. · PubMed · 1977 · 633 citations

Medicine, Internal Medicine, Autoimmunity +9

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

J.-Y. Douillard, Salvatore Siena, J Cassidy et al. · Annals of Oncology · 2014 · 604 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis

J Cassidy, Joseph E. Levinson, Juan Bass et al. · Arthritis & Rheumatism · 1986 · 426 citations · Full text

Medicine, Clinical Sciences, Pediatrics +9

Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties

Nga Chi Yip, Ivo S. Fombon, P Liu et al. · British Journal of Cancer · 2011 · 425 citations · Full text

Medicine, Oncology, Pharmacology +16